OCM
Osterweis Capital Management Portfolio holdings
AUM
$2.09B
This Quarter Return
+6.08%
1 Year Return
+16.35%
3 Year Return
+73.98%
5 Year Return
+137.82%
10 Year Return
+432.96%
AUM
$1.97B
AUM Growth
+$1.97B
(+2%)
Cap. Flow
+$87.2M
Cap. Flow
% of AUM
4.42%
Top 10 Holdings %
Top 10 Hldgs %
28.94%
Holding
211
New
12
Increased
47
Reduced
45
Closed
15
Top Buys
| 1 |
Hershey
HSY
|
$36.6M |
| 2 |
Broadcom
AVGO
|
$29.3M |
| 3 |
Intuit
INTU
|
$26.6M |
| 4 |
Deere & Co
DE
|
$21.8M |
| 5 |
Salesforce
CRM
|
$18.3M |
Top Sells
| 1 |
Target
TGT
|
$22.1M |
| 2 |
Union Pacific
UNP
|
$17.9M |
| 3 |
Microsoft
MSFT
|
$15.6M |
| 4 |
Analog Devices
ADI
|
$15M |
| 5 |
Synopsys
SNPS
|
$12.9M |
Sector Composition
| 1 | Technology | 24.54% |
| 2 | Healthcare | 16.66% |
| 3 | Consumer Discretionary | 11.33% |
| 4 | Industrials | 9.51% |
| 5 | Financials | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Magnolia Oil & Gas
MGY
$4.61B
| $10.9M | 0.55% | 445,165 +69,700 | +19% | +$1.7M |
|
52
Duolingo
DUOL
$13.6B
| $10.7M | 0.54% | 37,949 -19,485 | -34% | -$5.5M |
|
53
Eli Lilly
LLY
$657B
| $9.96M | 0.5% | 11,245 -240 | -2% | -$213K |
|
54
Natera
NTRA
$23.1B
| $9.64M | 0.49% | 75,910 -8,910 | -11% | -$1.13M |
|
55
RxSight
RXST
$370M
| $9.6M | 0.49% | 194,245 +77,305 | +66% | +$3.82M |
|
56
Verra Mobility
VRRM
$3.96B
| $9.46M | 0.48% | 340,030 +17,435 | +5% | +$485K |
|
57
Amicus Therapeutics
FOLD
$2.34B
| $9.45M | 0.48% | 884,820 +195,395 | +28% | +$2.09M |
|
58
Novartis
NVS
$245B
| – | – | 0 | – | – |
|
59
Klaviyo
KVYO
$9.73B
| $9.36M | 0.47% | +264,555 | New | +$9.36M |
|
60
Manhattan Associates
MANH
$13B
| $9.34M | 0.47% | 33,181 +5,388 | +19% | +$1.52M |
|
61
Evolent Health
EVH
$1.12B
| $8.78M | 0.44% | +310,305 | New | +$8.78M |
|
62
e.l.f. Beauty
ELF
$7.09B
| $8.59M | 0.44% | 78,789 +21,215 | +37% | +$2.31M |
|
63
UFP Technologies
UFPT
$1.62B
| $8.45M | 0.43% | 26,678 -5,968 | -18% | -$1.89M |
|
64
Onto Innovation
ONTO
$5.19B
| $8.03M | 0.41% | 38,697 -5,005 | -11% | -$1.04M |
|
65
Repligen
RGEN
$6.88B
| $7.95M | 0.4% | 53,445 +17,410 | +48% | +$2.59M |
|
66
Viking Therapeutics
VKTX
$3.04B
| $7.95M | 0.4% | 125,520 +41,665 | +50% | +$2.64M |
|
67
MACOM Technology Solutions
MTSI
$9.54B
| $7.79M | 0.39% | 70,030 -36,050 | -34% | -$4.01M |
|
68
Abercrombie & Fitch
ANF
$4.46B
| $7.31M | 0.37% | +52,275 | New | +$7.31M |
|
69
Clearwater Analytics
CWAN
$6.04B
| $7.31M | 0.37% | 289,565 +34,175 | +13% | +$863K |
|
70
SentinelOne
S
$6.29B
| $7.21M | 0.37% | +301,235 | New | +$7.21M |
|
71
CONMED
CNMD
$1.68B
| $6.94M | 0.35% | +96,465 | New | +$6.94M |
|
72
Zeta Global
ZETA
$4.68B
| $6.39M | 0.32% | +214,185 | New | +$6.39M |
|
73
Transmedics
TMDX
$3.92B
| $6.1M | 0.31% | 38,835 -17,905 | -32% | -$2.81M |
|
74
ACM Research
ACMR
$1.81B
| $5.79M | 0.29% | 285,256 +49,855 | +21% | +$1.01M |
|
|
75
Union Pacific
UNP
$133B
| $5.11M | 0.26% | 20,743 -72,486 | -78% | -$17.9M |
|